Skip to main content
All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CENTRIENT PHARMACEUTICALS LLC · Pharmaceutical Manufacturing

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income · posted Jul 21, 2025

Official filing document

 Lobbying activity 4
Health Issues

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Pharmacy

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Manufacturing

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Defense

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States; Issues related to the Defense Production Act (P.L. 115-232).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem